Trademark Attorney / Law Firm

John W. Ewart II – Trademark Portfolio

John W. Ewart II specializes in Class 42 (Computer & Scientific) trademark filings before the United States Patent and Trademark Office (USPTO), with 7 of 9 total filings concentrated in this category. The practice also covers Class 36 (Insurance & Financial) along with 2 other Nice Classification classes. Filing activity spans from 2021 to 2025. Currently, 1 trademark is registered and 3 are pending.

9 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

John W. Ewart II's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

42
Computer & Scientific (7 filings)

Scientific and technological services; industrial analysis and research services

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademark applications has John W. Ewart II filed?

John W. Ewart II has filed 9 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 3 pending, 4 abandoned, 1 cancelled.

What trademark classes does John W. Ewart II specialize in?

John W. Ewart II has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.

How long has John W. Ewart II been filing trademarks?

John W. Ewart II's trademark filing history with the USPTO spans from 2021 to 2025, covering 4 years of trademark practice. During this period, John W. Ewart II has handled 9 trademark applications.

What is John W. Ewart II's trademark registration success rate?

John W. Ewart II has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 3 applications are pending review.